Telesis Bio, Inc. ( TBIO) - Key Metrics
TBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.90 | -$3.83 | -$4.02 | -$4.05 |
| 2024Q2 | $0.90 | -$7.27 | -$3.09 | -$3.14 |
| 2024Q1 | $0.12 | -$0.29 | -$0.11 | -$0.13 |
| 2023Q4 | $0.23 | -$0.59 | -$0.24 | -$0.25 |
| 2023Q3 | $0.19 | -$0.35 | -$0.20 | -$0.20 |
TBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | 0% | -0.25 |
| 2024Q2 | 0% | -0.13 |
| 2024Q1 | 0% | -6.76 |
| 2023Q4 | 0% | -3.04 |
| 2023Q3 | 0% | -13.37 |
TBIO
Price: $0
52 week price:
Earnings Per Share: -27.65 USD
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 19200
Market Capitalization: 1775